Eirion Therapeutics to Present at the 2024 IMCAS World CongressFebruary 2, 2024 – Woburn, MA Eirion Therapeutics Inc., a biopharmaceutical company focused on developing innovative aesthetic...
Eirion Therapeutics Announces Initiation of First-in-Human Clinical Trial Eirion Therapeutics Announces Initiation of First-in-Human Clinical Trial Evaluating Next Generation, Ready-to-Use Liquid Injectable...
Eirion Therapeutics Announces Strategic Agreement with HTL Biotechnology Sep 08, 2021, 09:00 ET Eirion Therapeutics Announces Strategic Agreement for HTL Biotechnology to Become Eirion's Exclusive Botulinum API...